Sana Biotechnology, Inc. (SANA) Institutional Ownership

Ownership Summary

Sana Biotechnology, Inc. (NASDAQ:SANA) currently has 180 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The collective stake of institutional investors in Sana Biotechnology moved to 68.8% in September 2025, a shift up from the 63.2% reported for June 2025.
• The company experienced a 12.53% quarterly change in institutional shares held, alongside an increase of 15.38% in total owners annually.
• Among the 180 institutional holders of Sana Biotechnology, 105 added to their stakes while 46 trimmed their positions and 29 held steady.
• This class of investors increased its holdings in Sana Biotechnology to 163.66Mn shares for the 13F-cycle ending September 2025, up by 18.23Mn shares quarter on quarter, and up 9.85Mn shares year over year.
• As of September 30, 2025, FMR LLC held Sana Biotechnology's largest shareholding position with over 37.43Mn shares, representing 15.74% of total outstanding shares.
• Among the most significant buyers of Sana Biotechnology during September 2025 were STATE STREET CORP (3.82Mn), FMR LLC (3.60Mn), CITADEL ADVISORS LLC (3.15Mn), RENAISSANCE TECHNOLOGIES LLC (1.79Mn), VANGUARD GROUP INC (1.52Mn).
• Leading sellers of Sana Biotechnology stock in September 2025 included PRICE T ROWE ASSOCIATES INC /MD/ (2.41Mn), MORGAN STANLEY (603.29K), Crestline Management, LP (600.00K), Corient Private Wealth LLC (319.00K), MANUFACTURERS LIFE INSURANCE COMPANY, THE (242.89K).
• The top 10 institutional holders of Sana Biotechnology for the quarter ending September 2025 included FMR LLC (37.43Mn), Flagship Pioneering Inc. (25.00Mn), BAILLIE GIFFORD & CO (11.44Mn), BlackRock, Inc. (11.23Mn), CANADA PENSION PLAN INVESTMENT BOARD (10.18Mn), VANGUARD GROUP INC (9.13Mn), STATE STREET CORP (6.68Mn), CITADEL ADVISORS LLC (6.55Mn), Marex Group plc (3.82Mn), GEODE CAPITAL MANAGEMENT, LLC (3.42Mn).